P2.05. The Power for PD-L1 Expression to Predict Immune Checkpoint Blockade Outcomes is Determined by Tumor Transcriptome - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Anlin Li
Meta Tag
Speaker Anlin Li
Topic Metastatic NSCLC: Immunotherapy - Biomarker
WCLC 2023 conference
PD-L1 expression
immune checkpoint inhibitors
metastatic non-small cell lung cancer
tumor transcriptome
cross-cancer correlative analysis
multivariate Cox interaction test
transcriptomics-based PD-L1 power model
overall survival
objective response rate
Powered By